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Background
The purpose of this study was to examine the benefits
of inositol-stabilized arginine silicate (ASI; Nitrosigine®)
as a workout ingredient in healthy adults. ASI has been
previously shown to significantly enhance blood levels of
arginine up to six hours post-dose and increase nitric
oxide levels. To investigate reports of enhanced energy,
increased muscle pump and stamina during workouts,
and faster muscle recovery post-workout, ASI (1,500mg/
day) was tested in a double-blind placebo-controlled
crossover-design (DBPC-X) study using the POMS
vigor-activity and fatigue-inertia sub-scores, blood flow
measurements, leg circumference measurements, and
biomarkers of muscle recovery (creatine kinase (CK)
and lactate dehydrogenase (LDH)) as outcome measures.
Methods
The DBPC-X study was conducted in male subjects (N =
16 per group) who had limited exercise routines prior to
participating in the study. These subjects took ASI daily
for 4 days. Subjects had baseline measurements drawn at
the hour 0 visit, took the study product, and completed
an intense leg extension exercise protocol to induce mus-
cle soreness. Subjects returned after 24, 48, and 72 hours
for additional study measurements. After 72 hours, sub-
jects repeated the leg extension exercise protocol. There
was a seven-day washout between test products.
Between-product assessments were primary endpoints
and within-product assessments secondary endpoints.
Results
Sixteen (16) healthy male subjects (19-33 years of age)
completed the study. Perceived energy, measured using
the POMS vigor-activity sub-scores, significantly increased
after 72 hours compared to placebo (p = 0.039). At 72
hours, perceived fatigue, measured using the POMS fati-
gue-inertia sub-scores, significantly decreased in the ASI
group (p = 0.041) from pre-dose, compared to a non-sig-
nificant change in the placebo group (p = 0.580); p = 0.055
between groups.
Hyperemia, measured using leg circumference, increased
significantly in the ASI group by 1.8cm (p = 0.001) at
72 hours from pre-dose, compared to a non-significant
increase in the placebo group by 0.8cm (p = 0.091);
p = 0.070 between groups.
Blood flow, measured by blood velocity through the
femoral artery using a Doppler Ultrasound, increased
59.9 cm/s in the ASI group (p < 0.005) and 49.9cm/s in
the placebo group (p < 0.005) after exercise on Day 3;
p = 0.2 between groups.
CK levels significantly decreased in the ASI group at 24
(p = 0.040), 48 (p = 0.017) and 72 (p = 0.034) hours post-
exercise compared to the placebo group. Immediately
post-exercise at the hour 0 visit, ASI supplementation led
to 44% less muscle damage, measured by CK levels, than
placebo (p = 0.057). LDH levels significantly increased
from baseline immediately after exercise in the placebo
group (p = 0.015), but not in the ASI group (p = 0.366);
p = 0.133 between groups. No safety concerns were
raised by this study.
Conclusion
Both primary and secondary endpoints show that daily
doses of ASI prior to workout significantly increased pre-
workout energy levels, increased muscle pump immedi-
ately following a workout, and decreased biomarkers of
muscle damage immediately after a workout and during
recovery. These results demonstrate multiple benefits of
ASI as a functional workout ingredient.
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